FDA, Pharmaceutical Industry Reach Agreement On User-Fee Plan For Generics
The Washington Post: FDA And Drug Industry Agree On User-Fee Proposal For Generics
The Food and Drug Administration would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with the industry released by the agency on Friday (Perrone, 1/17).